By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pharming Group N.V. 

P.O. Box 451

AL Leiden    2300  The Netherlands
Phone: 31-0-71-524-7400 Fax: +31-0-71-521-6507


Company News
Pharming Group (PHGUF.PK) Announces Conclusion Of FDA End Of Phase II Interactions On RUCONEST For Prophylaxis Of HAE 9/11/2017 10:55:40 AM
Pharming Group (PHGUF.PK) Announces Cashless Warrant Exercises And Conversions Of Its Ordinary Bonds Into Shares 8/10/2017 10:50:19 AM
Pharming Group (PHGUF.PK) Reports On Financial Results For The First Half Of 2017 7/27/2017 10:56:22 AM
Pharming Group (PHGUF.PK) Announces Publication Of RUCONEST Prophylactic Data In Lancet 7/26/2017 10:53:32 AM
Pharming Group (PHGUF.PK) Interim Report On Financial Results For The First Quarter 2017 5/17/2017 12:50:11 PM
Pharming Group (PHGUF.PK) Announces Withdrawal Of Agenda Items Related To Amendment Of The Articles Of Association From AGM Agenda 5/17/2017 10:53:06 AM
Pharming Group (PHGUF.PK) Announces Refinancing Of Its Existing Debt By A Single US$100 Million Debt Facility On Improved Commercial Terms 5/16/2017 1:20:45 PM
Pharming Group (PHGUF.PK) Report On Preliminary Financial Results For 2016 3/9/2017 7:25:01 AM
Pharming Group (PHGUF.PK) Completes Transaction With Valeant (VRX) On Redemption Of All North American Rights RUCONEST 12/8/2016 10:56:22 AM
Pharming Group (PHGUF.PK) Announces Financing Plans For Closing Of RUCONEST North American Rights Acquisition 11/21/2016 10:17:17 AM